Finch Therapeutics Group, Inc.
FNCHDelisted Oct 31, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001733257
Finch Therapeutics Group, Inc. was delisted on Oct 31, 2024; its insiders filed their last Form 4 on Jun 10, 2024; no institution reported holding it in 13F filings for Q3 2024; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Finch Therapeutics Group, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 17 | 18 | +1 |
| Shares | 246.9K | 243.6K | −3.21K (−1.3%) |
| Value | $2.16M | $1.37M | −$789.3K (−36.6%) |
New holders (2)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| MSD Partners, L.P. | 5,113 | $26.5K | 0.00% |
| Moisand Fitzgerald Tamayo, LLC | 3 | $16 | 0.00% |
Sold out (1)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Bank of America Corp | 7 | $60 |